0
Editorial |

Nosocomial Transmission of Human Granulocytic Anaplasmosis?

Peter J. Krause, MD; Gary P. Wormser, MD
[+] Author Affiliations

Author Affiliations: Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, Connecticut (Dr Krause), and the Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, New York (Dr Wormser).


JAMA. 2008;300(19):2308-2309. doi:10.1001/jama.2008.665
Text Size: A A A
Published online

In this issue of JAMA, Zhang and colleagues describe a possible nosocomial outbreak of human granulocytic anaplasmosis (HGA) in China.1 The clinical presentation of the index case, a previously healthy 50-year-old woman who developed a febrile illness with rash and massive bleeding and who died 5 days later, is consistent with many infectious etiologies including viral hemorrhagic fever (VHF) for which she was given ribavirin.2 Laboratory studies in 9 subsequent cases in family members and health care workers who had contact with the patient, however, suggested that her disease was HGA.

Human granulocytic anaplasmosis is an emerging tick-borne infectious disease caused by Anaplasma phagocytophilum that occurs in Lyme disease–endemic areas in the United States and sporadically in Europe. Clinical manifestations of HGA are usually mild to moderate and most patients promptly respond to treatment with doxycycline, which neither the index patient nor the subsequent cases in this report received. Spontaneous resolution of HGA without antibiotic therapy also is well documented.3 - 4 Headache occurs in about three-quarters of cases of HGA, but diarrhea and rash are infrequent, and relative bradycardia has not been reported.3 ,5 Deaths from HGA occur in less than 1% of those infected and typically involve elderly persons or those who are immunocompromised, usually 10 or more days after disease onset.3 ,6

In the outbreak described by Zhang et al, the index case and all 9 of the secondary cases experienced fever with relative bradycardia, 7 had diarrhea, and 3 had headache. Thus, some of the clinical findings in these cases were atypical for HGA. The index case had a tick bite but also had exposure to mice and other animals before the onset of illness and therefore was at risk of a variety of infections. Transmission to the secondary cases most likely occurred through cutaneous or mucous membrane contact with blood or bloody respiratory secretions during a 12-hour period in the critical care unit when the index case underwent endotracheal intubation. In China, family members provide bedside care and so were present at the time of the patient's intubation and final hours. Use of personal protective devices such as gowns, gloves, or masks is sporadic at best. This could set the stage for transmission in a manner that would be unlikely in the United States.

Human granulocytic anaplasmosis replicates in neutrophils and can be transmitted by blood inoculation in experimental animals.7 There is also limited evidence for transmission to humans through blood transfusion.5 ,8 - 9 In a published report from the upper Midwest, 3 adults who had each recently butchered more than 250 deer and gave no report of tick bites developed HGA, possibly because of exposure to deer blood.10 Recent molecular microbiological studies, however, suggest that the strain of A phagocytophilum present in deer blood is a variant that has thus far not been documented to cause infections in humans.11 - 12 A plausible alternative explanation is that these individuals were unknowingly bitten by ticks that they encountered on the deer carcasses. Ixodes scapularis ticks were present on all 66 deer examined in one study from Westchester County, New York.13

In the report by Zhang et al, the index case died before antibody against A phagocytophilum would likely have been detectable and no residual blood or other tissue was available for postmortem polymerase chain reaction (PCR) testing. Among the secondary cases, the reported laboratory tests support the diagnosis of HGA. Amplification of A phagocytophilum HGA DNA was observed in all of the secondary cases and was further confirmed by direct nucleotide sequencing. DNA of A phagocytophilum can be detected in blood by PCR in about three-fourths of patients with HGA in the United States.14 As Zhang et al report, the genetic analysis revealed nucleotide sequences that more closely resembled a US strain of A phagocytophilum than strains known to exist in China, although the implications of this observation are unclear. A limitation of the outbreak investigation is that neither blood smears nor blood cultures for A phagocytophilum were reported to be positive.

Seroconversion against A phagocytophilum antigen was demonstrated by indirect immunofluorescence assay (IFA) in all the secondary cases and a 4-fold increase in antibody titer was found in 7 of the 9 patients. The maximum antibody titers were less than or equal to 1:256 in convalescent-phase samples, values that are lower than commonly observed in culture-confirmed cases of HGA in the United States where the titer is greater than or equal to 1:640 in more than 95% of seropositive patients.15 In a study from New York, the majority of unexplained low-titer IFA-positive results from serum samples could not be confirmed when retested by immunoblot, but that study population consisted of healthy blood donors rather than patients with an illness suspected to be HGA.16 The relatively low antibody titers observed in the Chinese outbreak might have resulted from infection with a strain of A phagocytophilum that differed from the one used for antigen preparation. Differences of this magnitude, however, were not commonly observed in studies from the United States that have compared different strains of A phagocytophilum used as antigen.15 ,17 It is unclear whether differences in the strains of A phagocytophilum between those found in China and those found in the United States and Europe might account for some of the other unusual clinical and epidemiological findings in this outbreak. More research on the implications of strain diversity is needed.

What is the significance of the investigation by Zhang et al? It may represent the first report of human-to-human transmission of A phagocytophilum and the first report of human HGA infection in China. This report certainly serves to reinforce the importance of adopting standard blood and body fluid precautions for all patients and especially for those with HGA; these precautions are the accepted standard of care in the United States. The report also should stimulate further investigation of the existence of A phagocytophilum in the region of China where this outbreak originated. In addition, it is essential to emphasize that fulfilling the case definition of HGA used for epidemiological surveillance in the United States does not provide diagnostic certainty, unless the diagnosis was established by the microbiological gold standard of culturing the microorganism. Therefore, the findings of the study by Zhang et al, while interesting and provocative, should be regarded as preliminary.

AUTHOR INFORMATION

Corresponding Author: Peter J. Krause, MD, Department of Epidemiology and Public Health, Yale School of Medicine, 60 College St, Room 600, PO Box 208034, New Haven, CT 065209 (peter.Krause@yale.edu).

Financial Disclosures: None reported.

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

Zhang L, Liu Y, Ni D,  et al.  Nosocomial transmission of human granulocytic anaplasmosis in China.  JAMA. 2008;300(19):2263-2270
CrossRef
Xu Z-Y, Guo C-S, Wu Y-L, Zhang X-W, Liu K. Epidemiologic studies of hemorrhagic fever with renal syndrome: analysis of risk factors and mode of transmission.  J Infect Dis. 1985;152(1):137-144
PubMedCrossRef
Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis.  JAMA. 1996;275(3):199-205
PubMedCrossRef
Krause PJ, McKay K, Thompson CA,  et al.  Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease.  Clin Infect Dis. 2002;34(9):1184-1191
PubMedCrossRef
Bakken JS, Dumler S. Human granulocytic anaplasmosis.  Infect Dis Clin North Am. 2008;22(3):433-448
PubMedCrossRef
Demma LJ, Holman RC, McQuiston JH, Krebs JW, Swerdlow DL. Epidemiology of human granulocytic ehrlichiosis and anaplasmosis in the United States, 2001-2002.  Am J Trop Med Hyg. 2005;73(2):400-409
PubMed
Madewell BR, Gribble DH. Infection in two dogs with an agent resembling Ehrlichia equi.  J Am Vet Med Assoc. 1982;180(5):512-514
PubMed
Leiby DA, Gill JE. Transfusion transmitted tick-borne infections: a cornucopia of threats.  Transfus Med Rev. 2004;18(4):293-306
PubMedCrossRef
Eastlund T, Persing D, Mathiesen D,  et al.  Human granulocytic ehrlichiosis after red cell transfusion [abstract].  Transfusion. 1999;39(suppl)  117S
Bakken JS, Krueth JK, Lund T, Malkovitch D, Asanovich K, Dumler JS. Exposure to deer blood may be a cause of human granulocytic ehrlichiosis.  Clin Infect Dis. 1996;23(1):198
PubMedCrossRef
Massung RF, Courtney JW, Hiratzka SL, Pitzer VE, Smith G, Dryden RL. Anaplasma phagocytophilum in white-tailed deer.  Emerg Infect Dis. 2005;11(10):1604-1606
PubMedCrossRef
Massung RF, Levin ML, Munderloh UG,  et al.  Isolation and propagation of the Ap-variant: 1 strain of Anaplasma phagocytophilum in a tick cell line.  J Clin Microbiol. 2007;45(7):2138-2143
PubMedCrossRef
Daniels TJ, Fish D, Levine JF,  et al.  Canine exposure to Borrelia burgdorferi and prevalence of Ixodes dammini (Acari: Ixodidae) on deer as a measure of Lyme disease risk in the northeastern United States.  J Med Entomol. 1993;30(1):171-178
PubMed
Bakken JS, Aguero-Rosenfeld ME, Tilden RL,  et al.  Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.  Clin Infect Dis. 2001;32(6):862-870
PubMedCrossRef
Aguero-Rosenfeld ME, Kalantarpour F, Baluch M,  et al.  Serology of culture-confirmed cases of human granulocytic ehrlichiosis.  J Clin Microbiol. 2000;38(2):635-638
PubMed
Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L,  et al.  Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis in different populations in Westchester County, New York.  J Clin Microbiol. 2002;40(7):2612-2615
PubMedCrossRef
Walls JJ, Aguero-Rosenfeld M, Bakken JS,  et al.  Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test.  J Clin Microbiol. 1999;37(9):2968-2973
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Zhang L, Liu Y, Ni D,  et al.  Nosocomial transmission of human granulocytic anaplasmosis in China.  JAMA. 2008;300(19):2263-2270
CrossRef
Xu Z-Y, Guo C-S, Wu Y-L, Zhang X-W, Liu K. Epidemiologic studies of hemorrhagic fever with renal syndrome: analysis of risk factors and mode of transmission.  J Infect Dis. 1985;152(1):137-144
PubMedCrossRef
Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis.  JAMA. 1996;275(3):199-205
PubMedCrossRef
Krause PJ, McKay K, Thompson CA,  et al.  Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease.  Clin Infect Dis. 2002;34(9):1184-1191
PubMedCrossRef
Bakken JS, Dumler S. Human granulocytic anaplasmosis.  Infect Dis Clin North Am. 2008;22(3):433-448
PubMedCrossRef
Demma LJ, Holman RC, McQuiston JH, Krebs JW, Swerdlow DL. Epidemiology of human granulocytic ehrlichiosis and anaplasmosis in the United States, 2001-2002.  Am J Trop Med Hyg. 2005;73(2):400-409
PubMed
Madewell BR, Gribble DH. Infection in two dogs with an agent resembling Ehrlichia equi.  J Am Vet Med Assoc. 1982;180(5):512-514
PubMed
Leiby DA, Gill JE. Transfusion transmitted tick-borne infections: a cornucopia of threats.  Transfus Med Rev. 2004;18(4):293-306
PubMedCrossRef
Eastlund T, Persing D, Mathiesen D,  et al.  Human granulocytic ehrlichiosis after red cell transfusion [abstract].  Transfusion. 1999;39(suppl)  117S
Bakken JS, Krueth JK, Lund T, Malkovitch D, Asanovich K, Dumler JS. Exposure to deer blood may be a cause of human granulocytic ehrlichiosis.  Clin Infect Dis. 1996;23(1):198
PubMedCrossRef
Massung RF, Courtney JW, Hiratzka SL, Pitzer VE, Smith G, Dryden RL. Anaplasma phagocytophilum in white-tailed deer.  Emerg Infect Dis. 2005;11(10):1604-1606
PubMedCrossRef
Massung RF, Levin ML, Munderloh UG,  et al.  Isolation and propagation of the Ap-variant: 1 strain of Anaplasma phagocytophilum in a tick cell line.  J Clin Microbiol. 2007;45(7):2138-2143
PubMedCrossRef
Daniels TJ, Fish D, Levine JF,  et al.  Canine exposure to Borrelia burgdorferi and prevalence of Ixodes dammini (Acari: Ixodidae) on deer as a measure of Lyme disease risk in the northeastern United States.  J Med Entomol. 1993;30(1):171-178
PubMed
Bakken JS, Aguero-Rosenfeld ME, Tilden RL,  et al.  Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.  Clin Infect Dis. 2001;32(6):862-870
PubMedCrossRef
Aguero-Rosenfeld ME, Kalantarpour F, Baluch M,  et al.  Serology of culture-confirmed cases of human granulocytic ehrlichiosis.  J Clin Microbiol. 2000;38(2):635-638
PubMed
Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L,  et al.  Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis in different populations in Westchester County, New York.  J Clin Microbiol. 2002;40(7):2612-2615
PubMedCrossRef
Walls JJ, Aguero-Rosenfeld M, Bakken JS,  et al.  Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test.  J Clin Microbiol. 1999;37(9):2968-2973
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics